Keyphrases
1-year Survival
6%
Acute Decompensated Heart Failure
12%
Adverse Events
7%
Atherosclerotic Risk Factors
5%
Bridge to Transplantation
12%
Cardiac Transplantation
8%
Cardiogenic Shock
8%
Cardiomyopathy
7%
Clinical Outcomes
8%
Confidence Interval
9%
Continuous-flow Left Ventricular Assist Device (CF-LVAD)
22%
Destination Therapy
9%
Device Complications
6%
Durable Mechanical Circulatory Support
6%
Expert Consensus Statement
5%
Gastrointestinal Bleeding
10%
Hazard Ratio
12%
Heart Allocation Policy
8%
Heart Failure
11%
Heart Failure with Preserved Ejection Fraction (HFpEF)
11%
Heart Transplant
9%
Heart Transplantation
25%
HeartMate 3
17%
HeartMate II
7%
Implantable Defibrillator
6%
INTERMACS
6%
Left Ventricular Assist Device
55%
Left Ventricular Assist Device Implantation
36%
Left Ventricular Assist Device Support
29%
Long-term Survival
6%
Low Dose Rate
5%
Lung Transplantation
10%
Maglev Technology
7%
Magnetically Levitated
6%
Mechanical Circulatory Support
10%
Medical Management
5%
Minnesota
6%
MOMENTUM 3
9%
Patient Management
9%
Pectoral muscle
12%
Prediction Model
6%
Pulmonary Arterial Hypertension
9%
Pulmonary Artery
5%
Pulmonary Hypertension
12%
Quality of Life
6%
Right Heart Failure
12%
Risk Score
9%
Supportive Therapy
6%
Transplantation
5%
United States
7%
Medicine and Dentistry
Adverse Event
7%
Apoplexy
19%
Assisted Circulation
23%
Atherosclerosis
8%
Cardiac Sarcoidosis
5%
Cardiogenic Shock
8%
Congestive Heart Failure
43%
Fluorodeoxyglucose F 18
5%
Gastrointestinal Bleeding
11%
Hazard Ratio
16%
Heart Failure with Preserved Ejection Fraction
5%
Heart Graft
14%
Heart Right Ventricle Failure
14%
Heart Transplantation
30%
Hemodynamic
5%
Implant
6%
Implantable Automatic Defibrillator
6%
Left Ventricular Assist Device
100%
Long Term Survival
6%
Lung Transplantation
9%
Meta-Analysis
5%
Myocardial Disease
6%
Positron Emission Tomography-Computed Tomography
5%
Proportional Hazards Model
5%
Pulmonary Artery
5%
Pulmonary Hypertension
12%
Quality of Life
7%
Reoperation
6%
Surgeon
5%
Survival Rate
5%
Systematic Review
5%